8-K - Syndax Pharmaceuticals Inc (0001395937) (Filer)
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Syndax Pharmaceuticals filed an 8-K with the SEC on Nov 2 (a notice of a material company event).
Directly affected
- SNDX Syndax Pharmaceuticals
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- LLY Eli Lilly and+15.5% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- JNJ Johnson & Johnson+0.1% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- PFE Pfizer+4.0% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- MRK Merck+3.5% 30d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| SNDX | +4.59% | +8.15% | base | +9.56% | -19.89% | -28.65% | -27.12% |
| XLV | -3.14% | -0.51% | base | -0.34% | +2.73% | +0.31% | +0.13% |
| XBI | +1.64% | +3.59% | base | +1.89% | +4.64% | -2.40% | +0.10% |
| LLY | -9.70% | -3.22% | base | -0.17% | +0.45% | -2.64% | -4.04% |
| JNJ | -1.08% | +1.28% | base | -1.63% | +2.13% | +0.67% | +2.13% |
| PFE | -3.81% | -3.29% | base | -2.38% | +0.26% | -2.70% | -4.31% |
| MRK | -4.78% | -1.78% | base | -2.55% | +1.29% | -0.75% | -1.14% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-02 AccNo: 0001193125-26-443613 Size: 7 MB Item 2.02: Results of Operations and Financial Condition Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory A…
Source: sec-edgar
Syndax Pharmaceuticals (SNDX) since this story, compared with the market
Since the first closing price after “8-K - Syndax Pharmaceuticals Inc (0001395937) (Filer),” Syndax Pharmaceuticals (SNDX) is -34.88%.
| Company | When | Move | Status |
|---|---|---|---|
| Johnson & Johnson (JNJ) | that day | -1.63% | final price |
| Johnson & Johnson (JNJ) | the next day | +2.13% | final price |
| Johnson & Johnson (JNJ) | two days later | +0.67% | final price |
| Johnson & Johnson (JNJ) | three days later | +2.13% | final price |
| Johnson & Johnson (JNJ) | three days earlier | +1.28% | final price |
| Johnson & Johnson (JNJ) | five days earlier | -1.08% | final price |
| Eli Lilly (LLY) | that day | -0.17% | final price |
| Eli Lilly (LLY) | the next day | +0.45% | final price |
| Eli Lilly (LLY) | two days later | -2.64% | final price |
| Eli Lilly (LLY) | three days later | -4.04% | final price |
| Eli Lilly (LLY) | three days earlier | -3.22% | final price |
| Eli Lilly (LLY) | five days earlier | -9.70% | final price |
| Merck (MRK) | that day | -2.55% | final price |
| Merck (MRK) | the next day | +1.29% | final price |
| Merck (MRK) | two days later | -0.75% | final price |
| Merck (MRK) | three days later | -1.14% | final price |
| Merck (MRK) | three days earlier | -1.78% | final price |
| Merck (MRK) | five days earlier | -4.78% | final price |
| Pfizer (PFE) | that day | -2.38% | final price |
| Pfizer (PFE) | the next day | +0.26% | final price |
| Pfizer (PFE) | two days later | -2.70% | final price |
| Pfizer (PFE) | three days later | -4.31% | final price |
| Pfizer (PFE) | three days earlier | -3.29% | final price |
| Pfizer (PFE) | five days earlier | -3.81% | final price |
| Syndax Pharmaceuticals (SNDX) | that day | +9.56% | final price |
| Syndax Pharmaceuticals (SNDX) | the next day | -19.89% | final price |
| Syndax Pharmaceuticals (SNDX) | two days later | -28.65% | final price |
| Syndax Pharmaceuticals (SNDX) | three days later | -27.12% | final price |
| Syndax Pharmaceuticals (SNDX) | three days earlier | +8.15% | final price |
| Syndax Pharmaceuticals (SNDX) | five days earlier | +4.59% | final price |
| Spdr Series Trust (XBI) | that day | +1.89% | final price |
| Spdr Series Trust (XBI) | the next day | +4.64% | final price |
| Spdr Series Trust (XBI) | two days later | -2.40% | final price |
| Spdr Series Trust (XBI) | three days later | +0.10% | final price |
| Spdr Series Trust (XBI) | three days earlier | +3.59% | final price |
| Spdr Series Trust (XBI) | five days earlier | +1.64% | final price |
| Select Sector Spdr Tr (XLV) | that day | -0.34% | final price |
| Select Sector Spdr Tr (XLV) | the next day | +2.73% | final price |
| Select Sector Spdr Tr (XLV) | two days later | +0.31% | final price |
| Select Sector Spdr Tr (XLV) | three days later | +0.13% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | -0.51% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -3.14% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 33 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 38 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 55 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 73 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 75 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Syndax Pharmaceuticals (SNDX)
Companies tied to this story
- SNDX Syndax Pharmaceuticals
For “8-K - Syndax Pharmaceuticals Inc (0001395937) (Filer),” Syndax Pharmaceuticals (SNDX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> SNDX
- XLV Select Sector Spdr Tr
For “8-K - Syndax Pharmaceuticals Inc (0001395937) (Filer),” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
- XBI Spdr Series Trust
In “8-K - Syndax Pharmaceuticals Inc (0001395937) (Filer),” Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence. Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
- LLY Eli Lilly
Eli Lilly (LLY) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “8-K - Syndax Pharmaceuticals Inc (0001395937) (Filer).” Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
- JNJ Johnson & Johnson
In “8-K - Syndax Pharmaceuticals Inc (0001395937) (Filer),” Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence. Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
- PFE Pfizer
Pfizer (PFE) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “8-K - Syndax Pharmaceuticals Inc (0001395937) (Filer).” Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
- MRK Merck
In “8-K - Syndax Pharmaceuticals Inc (0001395937) (Filer),” Merck (MRK) is linked, with no stored direction, medium confidence. Reason on file: Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
How “8-K - Syndax Pharmaceuticals Inc (0001395937) (Filer)” reaches Syndax Pharmaceuticals (SNDX)
On 2 Nov 2026, “8-K - Syndax Pharmaceuticals Inc (0001395937) (Filer)” is the story that connects Syndax Pharmaceuticals (SNDX) to this story.
The link for Syndax Pharmaceuticals (SNDX) is this: SEC 8-K filing -> direct issuer disclosure -> SNDX
A second company, Select Sector Spdr Tr (XLV), is listed for a different reason: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
Dates and price levels for Syndax Pharmaceuticals (SNDX)
SNDX traded between 9.29 and 14.49 across 4 sessions. The latest close on file is 9.32.
What the saved facts support for Syndax Pharmaceuticals (SNDX)
46 out of 100
“8-K - Syndax Pharmaceuticals Inc (0001395937) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.